Cabenuva/Apretude Collection

The American Academy of HIV Medicine is interested in medical providers who have begun using Cabenuva to treat HIV and/or Apretude as PrEP. Your responses will help us build out a web resource of best practices and other relevant information and create a database of providers nationwide.

Question Title

* 1. Have you started prescribing and/or dispensing injectable Cabenuva to treat HIV?

Yes

Question Title

* 2. Have you started prescribing and/or dispensing injectable Apretude to prevent HIV acquisition?

Yes

Question Title

* 3. What is your provider type?

Physician

Physician Assistant

Nurse Practitioner

Registered Nurse

Pharmacist

Other (please specify)

Question Title

* 4. Has your clinic or practice developed, flow sheets, acquisition and dispensing protocols, and other information to prescribe and/or dispense long-acting injectables?

Yes

Question Title

* 5. If you answered yes to question 4, would you be willing to share the information with the Academy?

Yes

Question Title

* 6. What is your contact information?

Name *

Company

City/Town

State/Province

ZIP/Postal Code

Email Address *

Phone Number *

Question Title

* 7. If you answered no to Question 4, which information would you like to receive (check all that apply)?

Protocols

Flow-Sheets

Product Acquisition Information

Product Storage Information

Billing and Coding Guidance

Prior Authorization Support

Patient Education Materials

Other (please specify)